Literature DB >> 18603557

Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias.

Anna Angela Di Tucci1, Gildo Matta, Simona Deplano, Attilio Gabbas, Cristina Depau, Daniele Derudas, Giovanni Caocci, Annalisa Agus, Emanuele Angelucci.   

Abstract

Only limited data are available regarding myocardial iron overload in adult patients with transfusion dependent acquired anemias. To address this topic using MRI T2* we studied 27 consecutive chronic transfusion dependent patients with acquired anemias: (22 myelodysplastic syndrome, 5 primary myelofibrosis). Cardiac MRI T2* values obtained ranged from 5.6 to 58.7 (median value 39.8) milliseconds. Of the 24 analyzable patients, cardiac T2* correlated with transfusion burden (p=0.0002). No patient who had received less than 290 mL/kg of packed red blood cells (101 units=20 grams of iron) had a pathological cardiac T2* value (< 20 ms). All patients who had received at least 24 PRBC units showed MRI T2* detectable hepatic iron (liver T2* value </=6.3 ms). Only patients with severe hepatic iron overload (T2* <1.4 ms) showed cardiac T2* value indicative of dangerous myocardial iron deposition. Serum ferritin was not significantly correlated with cardiac T2* (p=0.24). Gradient echo T2* magnetic resonance imaging provides a rapid and reproducible method for detecting myocardial iron overload which developed after a heavy transfusion burden equal to or greater than 290 mL/kg of packed red blood cell units.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603557     DOI: 10.3324/haematol.12759

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  32 in total

Review 1.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 2.  Iron chelation therapy in myelodysplastic syndromes: where do we stand?

Authors:  Mhairi Mitchell; Steven D Gore; Amer M Zeidan
Journal:  Expert Rev Hematol       Date:  2013-08       Impact factor: 2.929

3.  Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload.

Authors:  Toru Kiguchi; Yoshikazu Ito; Yukihiko Kimura; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2009-04-14       Impact factor: 2.490

4.  An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.

Authors:  Jelena Rascon; Lina Rageliene; Sigita Stankeviciene; Darius Palionis; Algirdas Edvardas Tamosiunas; Nomeda Valeviciene; Tadas Zvirblis
Journal:  Eur J Pediatr       Date:  2014-09       Impact factor: 3.183

Review 5.  Liver iron content determination by magnetic resonance imaging.

Authors:  Konstantinos Tziomalos; Vassilios Perifanis
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 6.  Evaluation of myocardial iron overload using magnetic resonance imaging.

Authors:  Sophie Mavrogeni
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

7.  Early cardiac iron overload in children with transfusion-dependent anemias.

Authors:  Juliano Lara Fernandes; Antonio Fabron; Monica Verissimo
Journal:  Haematologica       Date:  2009-10-08       Impact factor: 9.941

8.  Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.

Authors:  Emilio Paolo Alessandrino; Matteo Giovanni Della Porta; Andrea Bacigalupo; Luca Malcovati; Emanuele Angelucci; Maria Teresa Van Lint; Michele Falda; Francesco Onida; Massimo Bernardi; Stefano Guidi; Barbarella Lucarelli; Alessandro Rambaldi; Raffaella Cerretti; Paola Marenco; Pietro Pioltelli; Cristiana Pascutto; Rosi Oneto; Laura Pirolini; Renato Fanin; Alberto Bosi
Journal:  Haematologica       Date:  2009-11-10       Impact factor: 9.941

9.  Iron chelation therapy in myelodysplastic syndromes.

Authors:  Emanuela Messa; Daniela Cilloni; Giuseppe Saglio
Journal:  Adv Hematol       Date:  2010-06-20

10.  Iron overload in patients undergoing hematopoietic stem cell transplantation.

Authors:  Vinod Pullarkat
Journal:  Adv Hematol       Date:  2010-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.